KB RISE Bio TOP10 Active ETF UnitsKB RISE Bio TOP10 Active ETF UnitsKB RISE Bio TOP10 Active ETF Units

KB RISE Bio TOP10 Active ETF Units

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪18.76 B‬KRW
Fund flows (1Y)
‪5.82 B‬KRW
Dividend yield (indicated)
Discount/Premium to NAV
−0.03%
Shares outstanding
‪1.45 M‬
Expense ratio

About KB RISE Bio TOP10 Active ETF Units


Brand
KB RISE
Inception date
Dec 24, 2024
Structure
Open-Ended Fund
Index tracked
KRX Bio Top 10 Index - KRW - Benchmark TR Gross
Management style
Passive
Primary advisor
KB Asset Management Co. Ltd.
ISIN
KR70000Z0003

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Vanilla
Geography
South Korea
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


0000Z0 assets under management is ‪18.76 B‬ KRW. It's risen 26.81% over the last month.
0000Z0 fund flows account for ‪5.82 B‬ KRW (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 0000Z0 doesn't pay dividends to its holders.
0000Z0 shares are issued by KB Financial Group, Inc. under the brand KB RISE. The ETF was launched on Dec 24, 2024, and its management style is Passive.
0000Z0 follows the KRX Bio Top 10 Index - KRW - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
0000Z0 price has risen by 10.74% over the last month, and its yearly performance shows a 35.71% increase. See more dynamics on 0000Z0 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 8.18% over the last month, showed a 16.60% increase in three-month performance and has increased by 29.31% in a year.
0000Z0 trades at a premium (0.03%) meaning the ETF is trading at a higher price than the calculated NAV.